Prodrugs with enhanced penetration into cells

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) A61K 31/19 (2006.01) A61K 31/215 (2006.01) A61K 45/08 (2006.01) C07F 9/10 (2006.01)

Patent

CA 2159610

The invention relates to a pharmaceutically acceptable prodrug which is a covalent conjugate of a pharmacologically active compound and an intracellular transporting adjuvant, characterized by the presence of a covalent bond which is scission-sensitive to intracellular enzyme activity. The prodrug may be used in a technique for treating a condition or disease in a human related to supranormal intracellular enzyme (e.g. phospholipase and/or esterase) activity, whereby on administering it to a human having such condition or disease, the bond is broken in response to such activity, and the pharmacologically active compound accumulates selectively within cells having such supranormal intracellular enzyme activity. Exemplary conjugates are esters of the carboxylic function in the formula, with e.g. heptanoyl-sn-3--glycerophosphoryl-choline or octanoyl-sn-3-glycerophosphoryl- choline.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Prodrugs with enhanced penetration into cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prodrugs with enhanced penetration into cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prodrugs with enhanced penetration into cells will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2091883

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.